Apeikon raises €1.0M Seed round

1 March 2022· Barcelona, Spain· infrastructure, energy, ai, geospatial, b2b, software_hardware

The funding from the Innovate UK Biomedical Catalyst grant will be used to advance the company's image-guided targeted drug delivery platform for cancer treatment, specifically focusing on brain tumours.

Investors

LeadInnovate UK

About Apeikon

Stage
Pre-Seed
Headquarters
Barcelona, Spain
Founded
2021
Team Size
6–20
Sectors
infrastructureenergyaigeospatialb2bsoftware_hardware

Source: https://www.apeikon.co.uk/news/